|
Symbol Name ID |
Sh2d1b1
SH2 domain containing 1B1 MGI:1349420 |
Excel File
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Sh2d1b1/Sh2d1b2tm1.1Cpt/Sh2d1b1/Sh2d1b2tm1.1Cpt involves: BALB/cJ |
decreased interferon-gamma secretion | J:166054 |
| impaired natural killer cell mediated cytotoxicity | J:166054 | |
| Sh2d1b1tm1.1Cpt/Sh2d1b1tm1.1Cpt involves: BALB/cJ * C57BL/6 |
impaired natural killer cell mediated cytotoxicity | J:166054 |
| Sh2d1b1tm1Vei/Sh2d1b1tm1Vei involves: 129S1/Sv * 129X1/SvJ |
increased interferon-gamma secretion | J:110195 |
| increased natural killer cell mediated cytotoxicity | J:110195 | |
| Sh2d1b1tm3Vei/Sh2d1b1tm3Vei involves: C57BL/6 |
abnormal NK cell physiology | J:187430 |
| Tg(CD2-Sh2d1b1)#Vei/0 B6.Cg-Tg(CD2-Sh2d1b1)#Vei |
decreased interferon-gamma secretion | J:110195 |
| impaired natural killer cell mediated cytotoxicity | J:110195 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|
|
||
Analysis Tools